Gsk (GSK) Net Income (2009 - 2026)

Gsk's Net Income history runs 18 years deep, the most recent figure standing at $208.0 million for Q2 2026.

• In Q2 2026, Net Income fell 92.67% year-over-year to $208.0 million; the TTM figure through Jun 2026 stood at $14.0 billion (up 35.87% YoY), while the FY2025 annual figure was $8.3 billion, changed N/A from the prior year.
• Net Income for Q2 2026 stood at $208.0 million, down from $3.3 billion in the prior quarter.
• The five-year high for Net Income was $12.6 billion in Q4 2022, with the low at $81.9 million in Q3 2024.
• The 5-year median for Net Income is $2.8 billion (2023), against an average of $3.7 billion.
• The sharpest annual moves came in 2024 and 2025: Net Income tumbled 96.84% in 2024, then jumped 4462.94% in 2025.
• Gsk's Net Income stood at $12.6 billion in 2022, then slumped by 54.01% to $5.8 billion in 2023, then slipped by 24.92% to $4.3 billion in 2024, then surged by 56.77% to $6.8 billion in 2025, then slumped by 96.94% to $208.0 million in 2026.
• Business Quant data shows GSK's Net Income at $208.0 million in Q2 2026, $3.3 billion in Q1 2026, and $6.8 billion in Q4 2025.